Tech boost to drug reaction reporting

  • Date: 11 October 2018

DRUG reaction reporting has been made easier for hospital doctors thanks to new software. Reports of suspected side effects or 'adverse drug reactions' (ADRs) from medicines can now be made directly to the Medicines and Healthcare products Regulatory Agency (MHRA).

New functionality developed by software supplier Ulysses allows clinical systems to integrate with the Yellow Card system. This means adverse reaction or medication error reporting from hospitals and trusts is now easier than before.

Nottinghamshire Healthcare NHS Foundation Trust are the first to pilot this new integrated reporting across nearly 200 of their healthcare sites, where it is hoped the new software and increased accessibility will increase reporting of ADRs.

Implementing Yellow Card reporting functionality into clinical systems has previously resulted in increased ADR reporting, with over 37,700 suspected ADR reports from clinical systems received by the MHRA between 2010, when Yellow Card reporting of suspected ADRs was introduced into the first clinical system, and the end of August 2017.

MHRA’s Mick Foy said the development was “a great step forward for patient safety.”

Find out more at:

This page was correct at the time of publication. Any guidance is intended as general guidance for members only. If you are a member and need specific advice relating to your own circumstances, please contact one of our advisers.

Save this article

Save this article to a list of favourite articles which members can access in their account.

Save to library

Related Content

Coroner's inquests

Roundtable part 2 - Diagnosing conditions with a slower progression

Roundtable part 1 - Dealing with serious childhood illnesses

For registration, or any login issues, please visit our login page.